BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11118857)

  • 21. Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial.
    Gerna G; Lilleri D; Baldanti F; Torsellini M; Giorgiani G; Zecca M; De Stefano P; Middeldorp J; Locatelli F; Revello MG
    Blood; 2003 Jun; 101(12):5053-60. PubMed ID: 12586622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular-based strategies for assessment of CMV infection and disease in immunosuppressed transplant recipients.
    Kulkarni A; Westmoreland D; Fox JD
    Clin Microbiol Infect; 2001 Apr; 7(4):179-86. PubMed ID: 11422239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human cytomegalovirus (HCMV) leukodnaemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection.
    Gerna G; Zavattoni M; Baldanti F; Sarasini A; Chezzi L; Grossi P; Revello MG
    Transplantation; 1998 May; 65(10):1378-85. PubMed ID: 9625022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different profiles of cytomegalovirus RNA transcripts and anti-cytomegalovirus IgM antibodies in renal transplant recipients.
    Goossens VJ; Vink C; Mullers W; Middeldorp JM; Bruggeman CA
    J Clin Virol; 2001 Dec; 23(1-2):87-95. PubMed ID: 11595587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analytical performance and clinical utility of a nucleic acid sequence-based amplification assay for detection of cytomegalovirus infection.
    Witt DJ; Kemper M; Stead A; Sillekens P; Ginocchio CC; Espy MJ; Paya CV; Smith TF; Roeles F; Caliendo AM
    J Clin Microbiol; 2000 Nov; 38(11):3994-9. PubMed ID: 11060058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early detection of human cytomegalovirus infection after kidney transplantation by nucleic acid sequence-based amplification.
    Blok MJ; Christiaans MH; Goossens VJ; van Hooff JP; Sillekens P; Middeldorp JM; Bruggeman CA
    Transplantation; 1999 May; 67(9):1274-7. PubMed ID: 10342321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CMV infection of liver transplant recipients: comparison of antigenemia and molecular biology assays.
    Amorim ML; Cabeda JM; Seca R; Mendes AC; Castro AP; Amorim JM
    BMC Infect Dis; 2001; 1():2. PubMed ID: 11389774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of human cytomegalovirus gene expression in thoracic organ transplant recipients using nucleic acid sequence-based amplification.
    Oldenburg N; Lam KM; Khan MA; Top B; Tacken NM; McKie A; Mikhail GW; Middeldorp JM; Wright A; Banner NR; Yacoub M
    Transplantation; 2000 Oct; 70(8):1209-15. PubMed ID: 11063343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a new method for early detection of active cytomegalovirus infections. A study in kidney transplant recipients.
    Blok MJ; Christiaans MH; Goossens VJ; van Hooff JP; Top B; Middeldorp JM; Bruggeman CA
    Transpl Int; 1998; 11 Suppl 1():S107-9. PubMed ID: 9664957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients.
    Greijer AE; Verschuuren EA; Dekkers CA; Adriaanse HM; van der Bij W; The TH; Middeldorp JM
    J Infect Dis; 2001 Aug; 184(3):247-55. PubMed ID: 11443549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring of human cytomegalovirus infections in pediatric bone marrow transplant recipients by nucleic acid sequence-based amplification.
    Aono T; Kondo K; Miyoshi H; Tanaka-Taya K; Kondo M; Osugi Y; Hara J; Okada S; Yamanishi K
    J Infect Dis; 1998 Nov; 178(5):1244-9. PubMed ID: 9780242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of the human cytomegalovirus (HCMV) antigenemia assay for diagnosis and monitoring of HCMV infections and detection of antiviral drug resistance in the immunocompromised.
    Baldanti F; Revello MG; Percivalle E; Gerna G
    J Clin Virol; 1998 Jul; 11(1):51-60. PubMed ID: 9784143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of CMV disease in pediatric kidney transplant recipients: evaluation of pp67 NASBA-based pre-emptive ganciclovir therapy combined with CMV hyperimmune globulin prophylaxis in high-risk patients.
    Renoult E; Clermont MJ; Phan V; Buteau C; Alfieri C; Tapiero B
    Pediatr Transplant; 2008 Jun; 12(4):420-5. PubMed ID: 18466427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring of human Cytomegalovirus infection by antigenemia and viremia in the first 100 days following renal transplantation and relation to antiviral strategies.
    Terlizzi ME; Costa C; Astegiano S; Sidoti F; Vendrame R; Segoloni GP; Bergallo M; Cavallo R
    Minerva Med; 2008 Jun; 99(3):231-9. PubMed ID: 18497721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pp67 mRNA assay in treatment and monitoring of cytomegalovirus disease in renal transplant patients in India.
    Wattal C; Joshi S; Gupta A; Sharma A; Oberoi JK; Prasad KJ; Rana DS; Bhalla A; Khullar D
    Transpl Infect Dis; 2004 Jun; 6(2):90-2. PubMed ID: 15522113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of different assays for detection of human cytomegalovirus (HCMV) in predicting the development of HCMV disease in human immunodeficiency virus-infected patients.
    Blank BS; Meenhorst PL; Mulder JW; Weverling GJ; Putter H; Pauw W; van Dijk WC; Smits P; Lie-A-Ling S; Reiss P; Lange JM
    J Clin Microbiol; 2000 Feb; 38(2):563-9. PubMed ID: 10655346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients.
    Gerna G; Lilleri D; Zecca M; Alessandrino EP; Baldanti F; Revello MG; Locatelli F
    Haematologica; 2005 Apr; 90(4):526-33. PubMed ID: 15820949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring HCMV infection with quantitative real-time PCR in HCMV-positive orthotopic liver transplant recipients, and predictive factors for treatment of the first episode of HCMV viremia.
    Pillet A; Mengelle C; Basse G; Ribes D; Kamar N; Muscari F; Lavayssière L; Suc B; Esposito L; Peron JM; Rostaing L
    Transplant Proc; 2006 Sep; 38(7):2335-8. PubMed ID: 16980083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early virus isolation, early structural antigen detection and DNA amplification by the polymerase chain reaction in polymorphonuclear leukocytes from AIDS patients with human cytomegalovirus viraemia.
    Gerna G; Zipeto D; Parea M; Percivalle E; Zavattoni M; Gaballo A; Milanesi G
    Mol Cell Probes; 1991 Oct; 5(5):365-74. PubMed ID: 1665208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective evaluation of the clinical utility of different methods for the detection of human cytomegalovirus disease after liver transplantation.
    Seehofer D; Meisel H; Rayes N; Stein A; Langrehr JM; Settmacher U; Neuhaus P
    Am J Transplant; 2004 Aug; 4(8):1331-7. PubMed ID: 15268736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.